---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005699"
form_type: "8-K/A"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:27:19.583869+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics files 8-K/A to add auditor consent to Jan 10 filing

## Summary
- Amendment solely adds Exhibit 23.1, consent of Marcum LLP.
- No modifications to prior 8-K disclosure; no new financial or operational data.
- Filing date Feb 10, 2025; original report filed Jan 10, 2025.

## SEC filing metadata
- accession: 0001493152-25-005699
- form_type: 8-K/A
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315225005699/0001493152-25-005699-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315225005699/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005699
- JSON: https://secwatch.observer/filing/0001493152-25-005699.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005699.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.